2017
DOI: 10.1136/bmjopen-2017-017507
|View full text |Cite
|
Sign up to set email alerts
|

Protocol for a randomised controlled implementation trial of point-of-care viral load testing and task shifting: the Simplifying HIV TREAtment and Monitoring (STREAM) study

Abstract: IntroductionAchieving the Joint United Nations Programme on HIV and AIDS 90-90-90 targets requires models of HIV care that expand antiretroviral therapy (ART) coverage without overburdening health systems. Point-of-care (POC) viral load (VL) testing has the potential to efficiently monitor ART treatment, while enrolled nurses may be able to provide safe and cost-effective chronic care for stable patients with HIV. This study aims to demonstrate whether POC VL testing combined with task shifting to enrolled nur… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
27
0

Year Published

2018
2018
2024
2024

Publication Types

Select...
8

Relationship

4
4

Authors

Journals

citations
Cited by 21 publications
(28 citation statements)
references
References 43 publications
(26 reference statements)
0
27
0
Order By: Relevance
“…Our costing analysis was conducted within the Simplifying HIV TREAtment and Monitoring (STREAM) study, a randomized clinical trial of POC HIV VL monitoring in Durban, South Africa. [20] In STREAM, adult PLHIV who were stable on ART were randomized to receive either 1) POC HIV VL, CD4 count and creatinine monitoring and potential task-shifting to enrolled nurses, or 2) routine laboratory-based monitoring and standard South African HIV care. The STREAM trial was conducted at the CAPRISA eThekwini Research Clinic and the Prince Cyril Zulu Communicable Disease Centre, an urban government clinic providing primary care sexual health, HIV, and TB services.…”
Section: Methodsmentioning
confidence: 99%
“…Our costing analysis was conducted within the Simplifying HIV TREAtment and Monitoring (STREAM) study, a randomized clinical trial of POC HIV VL monitoring in Durban, South Africa. [20] In STREAM, adult PLHIV who were stable on ART were randomized to receive either 1) POC HIV VL, CD4 count and creatinine monitoring and potential task-shifting to enrolled nurses, or 2) routine laboratory-based monitoring and standard South African HIV care. The STREAM trial was conducted at the CAPRISA eThekwini Research Clinic and the Prince Cyril Zulu Communicable Disease Centre, an urban government clinic providing primary care sexual health, HIV, and TB services.…”
Section: Methodsmentioning
confidence: 99%
“…Clinical trials of POC viral load testing may facilitate task shifting to nurses and referral into differentiated care programs (Table 3) (47,48,(188)(189)(190). In one study, integrated POC monitoring using POC CD4 count (Pima), POC creatinine, and POC HIV viral load (Xpert HIV-1) is being evaluated to rapidly identify stable patients who can be seen by an enrolled/auxiliary nurse every 2 months and then be down-referred to a community ART delivery program, in which they are seen by a nurse every 6 months ( Fig.…”
Section: Looking Ahead: the Role Of Poc Hiv Viral Load Testing Withinmentioning
confidence: 99%
“…In one study, integrated POC monitoring using POC CD4 count (Pima), POC creatinine, and POC HIV viral load (Xpert HIV-1) is being evaluated to rapidly identify stable patients who can be seen by an enrolled/auxiliary nurse every 2 months and then be down-referred to a community ART delivery program, in which they are seen by a nurse every 6 months ( Fig. 4) (188). The primary outcome is viral suppression and retention in care after 12 months of POC monitoring, with secondary outcomes including costs of POC monitoring, time to receipt of results, time to adherence counseling, and time to switch to second-line ART.…”
Section: Looking Ahead: the Role Of Poc Hiv Viral Load Testing Withinmentioning
confidence: 99%
See 1 more Smart Citation
“… 48 Measures are being taken to strengthen EID programs and point of care virologic testing is gaining momentum, 10 , 49 51 and applications now extend to monitoring of pediatric and adult HIV treatment. 52 , 53 Over the past several years, new efforts have been made to find safe and potent ARVs with appropriate formulations and dosing for neonates and young infants 54 , 55 ( clinicaltrials.gov NCT01828073; NCT 02778204).…”
Section: Innovations Scientific Discovery and Collaboration: Diagnomentioning
confidence: 99%